Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dose Titration of LY2189265 in Overweight and Obese Patients With Type 2 Diabetes Mellitus

NCT00630825 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00630825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00630825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dose Titration of LY2189265 in Overweight and Obese Patients With Type 2 Diabetes Mellitus
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
January 31, 2009
Enrollment
262 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2